BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
Nov 4, 2020
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital Group LLC. The report discusses Craig-Hallum’s research coverage of PCSA and details the company’s experienced management team and its ownership rights to five programs that are de-risked by existing data. The piece reads, “By early next year, PCSA expects to begin three clinical trials – PCS499 in Phase IIb to treat necrobiosis lipoidica (‘NL’), PCS6422 in Phase Ia as an adjunct to the chemotherapy 5-FU, and PCS12852 in Phase IIa to treat constipation. We arrive at a $160M valuation using a DCF model with a blended 12% Probability of Success and 20% WACC. If any one of these programs is successful, the company could generate $200-300M in revenue within a few years and we like the odds with three clinical programs running in parallel.”
To view the full report, visit https://ibn.fm/i1aFT
About Processa Pharmaceuticals Inc.
The mission of Processa has been to develop products where existing clinical evidence of efficacy already exists in unmet medical need conditions — medical conditions where patients need treatment options that will improve survival and/or quality of life. The company has assembled a proven regulatory science development and management team and board of directors. The Processa development team has been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and 100 FDA meetings. For more information, visit the company’s website at www.ProcessaPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
How families are cutting the cost of Halloween as spending grows
Families are turning to homemade costumes, swaps and second-hand outfits to keep it affordable.
Firms 'holding back' on new jobs ahead of Budget
Some businesses say they want to see employment costs come down in the October Budget.
Will a new code end 'rip-off parking charges'?
The prime minister says a new code will end "rip-off parking charges" - but will it work?
Budget 2026: No more fat to trim for 'squeezed middle'
As the chancellor finalises his first Budget, how are the "squeezed middle" feeling about costs?
Four ways Labour could raise money in the Budget without hiking income tax
Chancellor John Healey may need to raise money to boost his fiscal headroom - BBC Verify examines what options could be on the table.
For Clues About How A.I. Will Change Work, Look to the Past
Economists hope earlier episodes of labor disruption, from the Industrial Revolution to the Great Depression, can help us prepare for the age of artificial intelligence.
Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
A postman’s son from Kentucky, he worked hard to lose his accent but never forgot his Appalachian roots. “The best stories come from west of the Potomac,” he said.
Six Flags to Add Seatbelts on Roller Coasters After Rider’s Death
The company said that all Six Flags rides and attractions would undergo safety reviews, as the park operator faces lawsuits over safety concerns.
Attention, Passengers: High Airfares May Be Here to Stay
Ticket prices jumped after fuel costs spiked because of the war with Iran, but airlines say even an end to the conflict will not bring fares back down quickly.
5 Takeaways From Our Investigation of Trump’s Waivers for Polluters
Chemical plants and other industrial facilities had been required to curb their toxic emissions. A New York Times investigation shows how they got out of it.
Rising demand from families needing Christmas help
Charlotte Riley says more families are reaching out for help for a variety of reasons.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.